Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis

By Vrieling Alina   Buck Katharina   Kaaks Rudolf   Chang-Claude Jenny  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and Progesterone Receptor Status as Prognostic Indicators in Patients with Optimally Cytoreduced Stage IIIc Serous Cystadenocarcinoma of the Ovary

By Geisler J.P.   Wiemann M.C.   Miller G.A.   Geisler H.E.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 424-427

Academic Press

Access to resources Recommend Favorite

miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status

By            

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1027-1032

Spandidos Publications

Access to resources Recommend Favorite

Estrogen Receptor Negative and Progesterone Receptor Positive Breast Carcinomas—How Frequent are they?

By Cserni Gábor  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 663-668

Springer Publishing Company

Access to resources Recommend Favorite

Progesterone receptor status of breast cancer metastases

By Branković-Magić M.   Janković R.   Nešković-Konstantinović Z.   Nikolić-Vukosavljević D.  

Journal of Cancer Research and Clinical Oncology, Vol. 128, Iss. 1, 2002-01 ,pp. : 55-60

Springer Publishing Company

Access to resources Recommend Favorite